|
|
冠状病毒(SARS-CoV-2)暴发:适用于药师和药房工作人员的信息与试行指南 |
国际药学联合会(International Pharmaceutical Federation,FIP) |
|
[1] |
BIBLIOGRAPHY Associa??o Nacional das Farmácias (Portugal). (January de 2020). Coronavírus 2019-nCoV: Interven??o da farmácia. Fonte: https://www. revistasauda. pt/SiteCollectionDocuments/ANFOnline/Fluxograma_CEDIMEFinal. pdf
|
[2] |
Centers for Disease Control and Prevention. (31 de January de 2020). 2019 Novel Coronavirus-Frequently asked questions and answers. Fonte: https://www. cdc. gov/coronavirus/2019-ncov/faq. html
|
[3] |
Centers for Disease Control and Prevention. (31 de January de 2020). How 2019-nCoV Spreads. Acesso em 1 de February de 2020, disponível em CDC-2019 Novel Coronavirus: https://www. cdc. gov/coronavirus/2019-ncov/about/transmission. html
|
[4] |
Centers for Disease Control and Prevention. (31 de January de 2020). Interim Guidance for Healthcare Professionals. Acesso em 1 de February de 2020, disponível em CDC-2019 Novel Coronavirus: https://www. cdc. gov/coronavirus/2019-nCoV/hcp/clinical-criteria. html#foot1
|
[5] |
Centers for Disease Control and Prevention. (2 de February de 2020). Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Patients Under Investigation (PUIs) for 2019 Novel Coronavirus (2019-nCoV). Fonte: https://www. cdc. gov/coronavirus/2019-nCoV/lab/guidelines-clinical-specimens. html
|
[6] |
Centers for Disease Control and Prevention. (3 de February de 2020). Interim Infection Prevention and Control Recommendations for Patients with Confirmed 2019 Novel Coronavirus (2019-nCoV) or Patients Under Investigation for 2019-nCoV in Healthcare Settings. Fonte: https://www. cdc. gov/coronavirus/2019-ncov/hcp/infection-control. html
|
[7] |
Centers for Disease Control and Prevention. (s. d. ). Three Key Factors Required for a Respirator to be Effective. Fonte: https://www. cdc. gov/niosh/npptl/pdfs/KeyFactorsRequiedResp01042018-508. pdf
|
[8] |
赵荣生,杨毅恒,杨丽,等. 新型冠状病毒感染:医院药学工作指导与防控策略专家共识[J].中国药学杂志,2020,55(4):268-277.
|
[9] |
LI F. Structure, Function, and Evolution of Coronavirus Spike Proteins. Annual Review of Virology, 3(1), 237-261. doi:10. 1146/annurev-virology-110615-042301
|
[10] |
Michelle L. Holshue, M. C. -C. (31 de January de 2020). First Case of 2019 Novel Coronavirus in the United States. New England Journal of Medicine, NA. doi:DOI: 10. 1056/NEJMoa2001191
|
[11] |
Ministry of Health of New Zealand. (3 de February de 2020). Interim Advice for Health Professionals: Novel Coronavirus (2019-nCoV). Fonte: https://www.health.govt.nz/system/files/documents/pages/interim_health_advice_for_health_professionals_novel_coronavirus_wuhan_2020_02_03. pdf
|
[12] |
Chen N S (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet, NA. Acesso em 4 de February de 2020, disponível em https://www. thelancet. com/journals/lancet/article/PIIS0140-6736(20)30211-7/fulltext
|
[13] |
Rothe C. (30 de January de 2020). Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. Fonte: New England Journal of Medicine-Correspondence: https://www. nejm. org/doi/full/10. 1056/NEJMc2001468
|
[14] |
Royal Pharmaceutical Society. (January de 2020). Wuhan novel coronavirus-Five key facts for pharmacy teams. Fonte: https://www. rpharms. com/resources/pharmacy-guides/wuhan-novel-coronavirus
|
[15] |
World Health Organization. (April de 2010). Guide to Local Production: WHO-recommended Handrub Formulations. Fonte: https://www. who. int/gpsc/5may/Guide_to_Local_Production. pdf
|
[16] |
World Health Organization. (28 de January de 2020). Advice on the use of masks in the community, during home care and in health care settings in the context of the novel coronavirus (2019-nCoV) outbreak. Fonte: https://www. who. int/publications-detail/advice-on-the-use-of-masks-the-community-during-home-care-and-in-health-care-settings-in-the-context-of-the-novel-coronavirus-(2019-ncov)-outbreak
|
[17] |
World Health Organization. (20 de January de 2020). Home care for patients with suspected novel coronavirus (nCoV) infection presenting with mild symptoms and management of contacts. Fonte: https://www. who. int/publications-detail/home-care-for-patients-with-suspected-novel-coronavirus-(ncov)-infection-presenting-with-mild-symptoms-and-management-of-contacts
|
[18] |
World Health Organization. (January de 2020). Novel Coronavirus (2019-nCoV) advice for the public. Fonte: https://www. who. int/emergencies/diseases/novel-coronavirus-2019/advice-for-public
|
[19] |
World Health Organization. (January de 2020). Novel Coronavirus (2019-nCoV) advice for the public: Myth busters. Fonte: https://www. who. int/emergencies/diseases/novel-coronavirus-2019/advice-for-public/myth-busters
|
[20] |
World Health Organization. (27 de January de 2020). Novel Coronavirus(2019-nCoV)-Situation report 7. Fonte: https://www. who. int/docs/default-source/coronaviruse/situation-reports/20200127-sitrep-7-2019--ncov. pdf
|
[21] |
World Health Organization. (9 de January de 2020). Q&A on coronaviruses. Fonte: https://www. who. int/news-room/q-a-detail/q-a-coronaviruses
|
[22] |
World Health Organization. (27 de January de 2020). Updated WHO advice for international traffic in relation to the outbreak of the novel coronavirus 2019-nCoV. Fonte: https://www. who. int/ith/2019-nCoV_advice_for_international_traffic/en/
|
[23] |
World Health Orzanization. (25 de January de 2020). Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected: interim guidance. Fonte: https://www. who. int/publications-detail/infection-prevention-and-control-during-health-care-when-novel-coronavirus-(ncov)-infection-is-suspected-20200125
|
[1] |
张竞文, 胡欣, 金鹏飞. 新型冠状病毒引起的细胞因子风暴及其药物治疗[J]. 中国药学杂志, 2020, 55(5): 333-336. |
[2] |
赵瑞, 杭永付, 刘星星, 谈心, 杨漾, 陈琳, 包健安, 缪丽燕. 我院慢性肾脏病患者药物重整服务模式的建立[J]. 中国药学杂志, 2020, 55(5): 408-412. |
[3] |
赵荣生, 杨毅恒, 杨丽, 李子健, 刘芳, 任振宇, 刘维, 易湛苗, 应颖秋, 李潇潇, 闫盈盈, 李慧博, 董淑杰, 石伟龙, 徐晓涵, 周鹏翔, 宋再伟, 郑思骞, 刘颖, 周燊. 新型冠状病毒感染:医院药学工作指导与防控策略专家共识[J]. 中国药学杂志, 2020, 55(4): 268-277. |
[4] |
王婧雯, 关月, 曹珊珊, 陈苏宁, 赵瑾怡, 张维, 牟菲, 蔺瑞, 葛洁, 王化宁, 刘亮. 新型冠状病毒感染:零售药店工作指导与防控策略专家共识[J]. 中国药学杂志, 2020, 55(4): 278-283. |
[5] |
都丽萍, 李莹, 李玲玲, 保芸, 尤国皎, 任爽, 张波, 梅丹. 药师干预对华法林抗凝治疗质量的影响[J]. 中国药学杂志, 2019, 54(9): 749-752. |
[6] |
李全志, 李伟, 兰玲, 邓微, 甄健存. 内分泌临床药师对2型糖尿病患者慢病管理的随机对照研究[J]. 中国药学杂志, 2019, 54(7): 588-591. |
[7] |
迟丹怡, 王斌, 钟明康. 从一例患者药物治疗管理探讨抗胆碱药与胆碱酯酶抑制剂间的处方级联[J]. 中国药学杂志, 2019, 54(5): 411-414. |
[8] |
周欣,李娟,杨佳丹,姚高琼,张成志,邱峰. 从营养支持病例实践探讨营养支持药师在临床营养支持中的作用[J]. 中国药学杂志, 2019, 54(4): 334-337. |
[9] |
黄元楷, 姚东宁, 席晓宇, 王艺, 王筱婧, 王一涛, 姚文兵. 我国二级医院临床药学服务现状及问题研究(三):临床药学服务相关者态度意向分析[J]. 中国药学杂志, 2019, 54(3): 245-252. |
[10] |
谢菡, 马正良, 仇毓东, 陈正香, 范晴晴, 王少红, 丁艺, 葛卫红. 临床药师参与术后患者自控镇痛泵管理的工作模式与成效[J]. 中国药学杂志, 2019, 54(19): 1622-1625. |
[11] |
王先利, 黄燕萍, 庞艳玉, 汤静. PDCA循环管理法在妇产科医院临床药师绩效管理中的应用[J]. 中国药学杂志, 2019, 54(18): 1534-1538. |
[12] |
覃旺军, 刘莹, 王晓星, 李朋梅, 邓昂, 张相林. 疼痛专科临床药师会诊在综合医院疼痛治疗中的作用[J]. 中国药学杂志, 2019, 54(11): 930-933. |
[13] |
李纳, 刘楠, 汤姝, 孟海阳, 张晓坚. 临床药师参与1例肺移植患者个体化治疗的药学实践[J]. 中国药学杂志, 2019, 54(10): 834-838. |
[14] |
侯珂露, 杨媛华, 王子惠, 龚娟妮, 邝土光, 崔向丽, 刘丽宏. 临床药师参与肺栓塞患者抗凝治疗管理的效果评价[J]. 中国药学杂志, 2018, 53(8): 646-651. |
[15] |
陈玥, 王秀英, 刘磊. 一例危重症患者抗感染治疗的药学监护[J]. 中国药学杂志, 2018, 53(7): 565-568. |
|
|
|
|